What our clients say about us



“Bioscience IP has provided the board with invaluable support when it has come to establishing a patent strategy for protecting our FRUITFLOW product. Their knowledge of our sector and patent expertise has made this firm a first place to turn when we need advice on patent related matters” Ian Ford, Finance Director, Provexis plc

"Evgen uses Bioscience IP as a trusted IP advisor. They have prepared insightful reports that have helped the board develop its IP strategy, conducted patent landscaping exercises on our behalf and Paul is always available to deliver clear presentations at our board meetings. In our view it is very difficult to find a patent attorney who delights in understanding the bigger picture and then provides pragmatic advice that is entirely focused on your needs – Bioscience IP hit the mark in this respect " Steve Franklin, CEO, Evgen Limited

"Paul Banford of Bioscience IP has lectured for us and presented seminars relating to IP. Most recently he has contributed to teaching on one of our Masters Degree courses. We are delighted with his presentation skills, as-well-as the content, and hope Bioscience IP can continue to work with us" Dr Curtis Dobson, The University of Manchester

“SIS uses Bioscience IP  for  strategic guidance  with regards managing its patent portfolio, conducting patent
landscaping exercises, providing patent  infringement and validity opinions and for monitoring and advising on competitor activity. The firm’s work has played a major part in our aim to optimise our IP position and I certainly know where to turn if I have a query relating to patents!” Luke Heeney, New Products Director, Science in Sport plc

“Bioscience IP has assisted UMI3 by providing IP training seminars covering patent searching and also patents as a source of information. I would not hesitate to recommend this consultancy if you need well delivered presentations that are tailored such that the content perfectly matches the subject matter in which you have expressed an interest” Dr Rich Ferrie, Director of Operations, UMI3 Limited

"We were recommended to use this consultancy if we wanted a detailed and impartial review of the intellectual property strategy that is at the core of our business model. We were not disappointed! Bioscience IP’s Report has provided invaluable IP guidance as we advance our drug development programmes.” Jeremy Skillington, PhD, CEO, TriMod Therapeutics Limited